🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the recommended Phase IIa dose (RP2D) of the triplet combinati...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2024-12-31
Trial ID
NCT06683755
Treatments Being Tested
This phase 3 trial compares the addition of nivolumab to chemotherapy (carb...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2020-11-17
Trial ID
NCT04444921
Treatments Being Tested
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
This phase I trial evaluates the effects of CBM588 in combination with stan...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2021-11-01
Trial ID
NCT05122546
Treatments Being Tested
The primary hypothesis is that cancer vaccine can convert non-immunogenic g...
Status
Unknown
Location
National University Hospital
Start Date
2019-02-21
Trial ID
NCT03784040
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of nivolum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-03
Trial ID
NCT05272384
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
The purpose of this study is to assess the safety and efficacy of the combi...
Status
Completed
Location
St George's University Hospitals NHS Foundation Trust
Start Date
2018-10-04
Trial ID
NCT03711188
Treatments Being Tested
Subjects with resectable melanoma will receive neoadjuvant nivolumab follow...
Status
Active Not Recruiting
Location
Duke Cancer Institute
Start Date
2020-01-01
Trial ID
NCT04013854
Treatments Being Tested
The purpose is to determine the safety, effectiveness and best dose to use ...
Status
Completed
Location
City Of Hope
Start Date
2012-02-09
Trial ID
NCT01472081
Treatments Being Tested